Provided by Tiger Fintech (Singapore) Pte. Ltd.

AngioDynamics

9.41
-0.1750-1.83%
Volume:59.02K
Turnover:554.58K
Market Cap:381.91M
PE:-9.25
High:9.50
Open:9.48
Low:9.31
Close:9.58
Loading ...

Company Profile

Company Name:
AngioDynamics
Exchange:
NASDAQ
Establishment Date:
1988
Employees:
748
Office Location:
14 Plaza Drive,Latham,New York,United States
Zip Code:
12110
Fax:
- -
Introduction:
AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

Directors

Name
Position
Howard W. Donnelly
Chairman of the Board
James C. Clemmer
Director,President and Chief Executive Officer
Dennis S. Meteny
Director
Eileen O. Auen
Director
Jan Reed
Director
Karen A. Licitra
Director
Lorinda A. Burgess
Director
Michael E. Tarnoff
Director
Wesley E. Johnson, Jr.
Director

Shareholders

Name
Position
James C. Clemmer
Director,President and Chief Executive Officer
Chad T. Campbell
Senior Vice President and General Manager, Vascular Access and Oncology
David D. Helsel
Senior Vice President, Global Operations and Research and Development
Laura Piccinini
Senior Vice President and General Manager, International
Scott Centea
Senior Vice President and General Manager, Endovascular Therapies
Stephen A. Trowbridge
Executive Vice President, Chief Financial Officer